Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Supplement 1 , Pages S15-S29, December 2006

Aromatase inhibitors: effective endocrine therapy in the early adjuvant setting for postmenopausal women with hormone-responsive breast cancer

  • Louis Mauriac (Medical Oncologist)

      Affiliations

    • Corresponding Author InformationTel.: +33 5 56 33 32 58; Fax: +33 5 56 33 33 85.

Regional Cancer Centre, Department of Medicine, Institut Bergonié, 229 Cours de l'Argonne, 33076 Bordeaux Cedex, France

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(06)00082-0

doi:10.1016/j.beem.2006.10.003

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Supplement 1 , Pages S15-S29, December 2006

Article Tools

* Image Usage & Resolution